SCHEMBL6234872

SCHEMBL6234872

CC(C)CN1C(=O)c2cc(Br)ccc2C1O.CC(C)CN1C(=O)c2ccc(Br)cc2C1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
ALOX15 P16050 1/20 0.41
PRMT5 O14744 4/20 0.36
WDR77 Q9BQA1 4/20 0.36
ALDH1A1 P00352 3/20 0.35
GAA P10253 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BCL2 P10415 1/20 0.35
MCL1 Q07820 1/20 0.35
PKM P14618 1/20 0.34
CACNA1B Q00975 3/20 0.34
KMT2A Q03164 2/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4473294 0.95 CACNA1B (0.37) KDM4EPOLBALOX15PRMT5WDR77
SCHEMBL4481397 0.95 KDM4E (0.45) KDM4EPOLBALOX15ALDH1A1GAA
SCHEMBL4459334 0.80 NPC1 (0.39) KDM4EPOLBALOX15ALDH1A1GAA
SCHEMBL4459450 0.80 KDM4E (0.46) KDM4EPOLBALOX15ALDH1A1GAA
SCHEMBL4486595 0.79 KDM4E (0.43) KDM4EPOLBALOX15ALDH1A1GAA
SCHEMBL4477266 0.79 KDM4E (0.45) KDM4EPOLBALOX15ALDH1A1GAA
SCHEMBL4466267 0.79 LMNA (0.41) KDM4EPOLBALOX15ALDH1A1LMNA
SCHEMBL6234847 0.78 HPGD (0.55) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL4468989 0.78 HPGD (0.55) ALDH1A1LMNAHPGDNPC1RAB9A
SCHEMBL25098665 0.77 KDM4E (0.44) KDM4EPOLBALOX15ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528923-A1 N-((3-OXO-2,3-DIHYDRO-1H-ISOINDOL-1-YL)ACETYL)GUANIDINE DERIVATIVES AS NHE1-INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS Aventis Pharma Deutschland GmbH (DE) 2005-05-11 EP disclosed
WO-2003101450-A1 N- ((3-OXO2, 3-DIHYDRO-1H-ISOINDOL-1-YL) ACETYL) GUANIDINE DERIVATIVES AS NHE-1 INHIBITORS FOR THE TREATMENT OF INFARCTION AND ANGINA PECTORIS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed